Compare Piramal Healthcare with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs FULFORD INDIA - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES FULFORD INDIA PIRAMAL ENTERPRISES/
FULFORD INDIA
 
P/E (TTM) x 13.7 398.8 3.4% View Chart
P/BV x 0.9 6.2 14.0% View Chart
Dividend Yield % 2.0 0.1 2,405.3%  

Financials

 PIRAMAL ENTERPRISES   FULFORD INDIA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
FULFORD INDIA
Mar-14
PIRAMAL ENTERPRISES/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs3,303942 350.6%   
Low Rs1,797450 399.3%   
Sales per share (Unadj.) Rs716.5691.4 103.6%  
Earnings per share (Unadj.) Rs79.711.5 695.4%  
Cash flow per share (Unadj.) Rs107.915.4 702.5%  
Dividends per share (Unadj.) Rs28.002.00 1,400.0%  
Dividend yield (eoy) %1.10.3 382.2%  
Book value per share (Unadj.) Rs1,477.5380.0 388.8%  
Shares outstanding (eoy) m184.453.90 4,729.5%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.61.0 353.5%   
Avg P/E ratio x32.060.7 52.7%  
P/CF ratio (eoy) x23.645.3 52.1%  
Price / Book Value ratio x1.71.8 94.2%  
Dividend payout %35.117.4 201.3%   
Avg Mkt Cap Rs m470,2922,714 17,325.8%   
No. of employees `0007.80.4 1,761.3%   
Total wages/salary Rs m22,504505 4,456.1%   
Avg. sales/employee Rs Th16,899.46,073.0 278.3%   
Avg. wages/employee Rs Th2,877.71,137.4 253.0%   
Avg. net profit/employee Rs Th1,879.9100.7 1,867.3%   
INCOME DATA
Net Sales Rs m132,1532,696 4,901.1%  
Other income Rs m3,128125 2,494.4%   
Total revenues Rs m135,2812,822 4,794.2%   
Gross profit Rs m66,290-46 -142,865.5%  
Depreciation Rs m5,20215 34,220.4%   
Interest Rs m44,09710 464,183.2%   
Profit before tax Rs m20,11954 37,051.0%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,61110 89,701.0%   
Profit after tax Rs m14,70145 32,888.6%  
Gross profit margin %50.2-1.7 -2,915.0%  
Effective tax rate %42.817.7 242.1%   
Net profit margin %11.11.7 671.0%  
BALANCE SHEET DATA
Current assets Rs m122,7421,738 7,061.1%   
Current liabilities Rs m310,810545 57,060.7%   
Net working cap to sales %-142.344.3 -321.5%  
Current ratio x0.43.2 12.4%  
Inventory Days Days2348 47.6%  
Debtors Days Days394 902.3%  
Net fixed assets Rs m116,90412 982,388.2%   
Share capital Rs m36939 945.9%   
"Free" reserves Rs m272,1611,443 18,860.8%   
Net worth Rs m272,5301,482 18,389.4%   
Long term debt Rs m270,1960-   
Total assets Rs m856,2612,077 41,231.8%  
Interest coverage x1.56.7 21.7%   
Debt to equity ratio x1.00-  
Sales to assets ratio x0.21.3 11.9%   
Return on assets %6.92.6 263.1%  
Return on equity %5.43.0 178.8%  
Return on capital %12.44.3 288.5%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m15,20017 88,374.4%   
Fx outflow Rs m4,889673 726.2%   
Net fx Rs m10,312-656 -1,572.0%   
CASH FLOW
From Operations Rs m-115,97590 -128,860.7%  
From Investments Rs m-8,265105 -7,901.6%  
From Financial Activity Rs m107,525-14 -762,587.2%  
Net Cashflow Rs m-16,650181 -9,224.5%  

Share Holding

Indian Promoters % 52.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.0 3.8 105.3%  
FIIs % 26.6 0.1 26,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 21.2 77.8%  
Shareholders   93,274 4,783 1,950.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  PROCTER & GAMBLE HEALTH  ABBOTT INDIA  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 93 Points Higher; Oil & Gas and Realty Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the oil & gas sector.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 16, 2019 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - GLENMARK PHARMA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS